General Prognostics
Boston, US · Founded 2020 · Delaware corporation · 1 known investors
Founders & leadership
SM
Sean MatsuokaNamed on SEC filing
JE
Javier EcheniqueNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$810K disclosed across 2 rounds · 2020–2024
▶$200KraisedAug 2024 · 2 investors · Other Health CareRule 506(b)
▶$200KraisedAug 2024 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sean MatsuokaExecutive Officer, Director
- Javier EcheniqueExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $200K
- Proceeds to insiders
- $500K
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$610KraisedNov 2023 · 8 investors · Other Health CareRule 506(b)
▶$610KraisedNov 2023 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sean MatsuokaExecutive Officer, Director
- Javier EcheniqueExecutive Officer, Director
- Offering amount
- $3.3M
- Amount sold
- $610K
- Proceeds to insiders
- $140K
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are General Prognostics's investors?
- General Prognostics's investors include D4V (Design for Ventures).
- How much funding has General Prognostics raised?
- General Prognostics has disclosed $810K raised across 2 rounds.
- Where is General Prognostics headquartered?
- General Prognostics is headquartered in Boston, US.